Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD

NCT05133804 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG: Methylphenidate
DRUG: Reboxetine
DRUG: Placebo
DRUG: Placebo

Sponsor

University of Haifa